CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 10 enrolled
Drug / intervention
Methacholine Chloride (SK-1211)drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02097537
NCT02097537Phase 3Completed
CompareCT.gov

Study of Methacholine Chloride Inhalation Challenge in Children With Bronchial Asthma

Santen Pharmaceutical Co., Ltd.·interventional·Posted Mar 27, 2014·Updated Mar 29, 2017

In Brief

A Phase 3 clinical trial evaluating Methacholine Chloride (SK-1211) for Asthma. Completed, enrolled 10 participants across 1 site.

Detailed Summary

The Purpose of this study is to evaluate the safety and efficacy of SK-1211 inhalation challenge in children with bronchial asthma.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesJapan
Collaborators--

Timeline

Phase 3CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedMar 27, 2014
Enrollment StartFeb 1, 2014
Primary CompletionJul 1, 2014
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 12.3 years ago

Interventions

Methacholine Chloride (SK-1211)drug